Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by ORIX CORP
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-193297 (34 Act) Size: 517 KB |
Aug-05-2024 | 241173020 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-174626 (34 Act) Size: 26 KB |
Jul-03-2024 | 241098194 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-171207 (34 Act) Size: 478 KB |
Jun-28-2024 | 241081304 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-169606 (34 Act) Size: 39 KB |
Jun-27-2024 | 241075224 |
20-F | Document | Annual and transition report of foreign private issuers pursuant to sections 13 or 15(d) Acc-no: 0001193125-24-169594 (34 Act) Size: 65034 KB |
Jun-27-2024 | 241075215 |
6-K/A | Document | Amendment to Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-162955 (34 Act) Size: 235 KB |
Jun-18-2024 | 241050111 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-154637 (34 Act) Size: 26 KB |
Jun-05-2024 | 241020633 |
SD | Document | Acc-no: 0001193125-24-149565 (34 Act) Size: 26 KB | May-30-2024 | 241000597 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-147516 (34 Act) Size: 4493 KB |
May-28-2024 | 24986152 |
13F-HR | Document | Initial Quarterly Form 13F Holdings report filed by institutional managers Acc-no: 0000950123-24-004809 (34 Act) Size: 4 KB |
May-14-2024 | 24941367 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-133734 (34 Act) Size: 538 KB |
May-08-2024 | 24924121 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-059937 (34 Act) Size: 84 KB |
Mar-06-2024 | 24724286 |
13F-HR | Document | Initial Quarterly Form 13F Holdings report filed by institutional managers Acc-no: 0000950123-24-001634 (34 Act) Size: 4 KB |
Feb-13-2024 | 24622495 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-032787 (34 Act) Size: 50477 KB |
Feb-13-2024 | 24622471 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-025862 (34 Act) Size: 268 KB |
Feb-07-2024 | 24601982 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001086364-24-006699 (34 Act) Size: 13 KB |
Feb-06-2024 | 24598460 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001214659-24-001873 (34 Act) Size: 36 KB |
Feb-05-2024 | 24593877 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-24-008015 (34 Act) Size: 486 KB |
Jan-16-2024 | 24533526 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-23-294861 (34 Act) Size: 32 KB |
Dec-14-2023 | 231485504 |
6-K | Document | Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001193125-23-292024 (34 Act) Size: 39 KB |
Dec-11-2023 | 231476835 |
Recent 20 filings. View all ORIX CORP filings
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Thanks I look forward to using the product to improve my skin tone
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by